Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret Share Price

Equities

ANGEN

TREANGN00028

Biotechnology & Medical Research

Market Closed - Borsa Istanbul 16:08:01 30/04/2024 BST 5-day change 1st Jan Change
13.28 TRY -1.12% Intraday chart for Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret -5.41% +6.67%

Financials

Sales 2021 410M 12.64M 1.01B Sales 2022 269M 8.28M 663M Capitalization 4.74B 146M 11.68B
Net income 2021 433M 13.34M 1.07B Net income 2022 330M 10.17M 813M EV / Sales 2021 6.59 x
Net cash position 2021 511M 15.73M 1.26B Net cash position 2022 411M 12.67M 1.01B EV / Sales 2022 16.1 x
P/E ratio 2021
5.1 x
P/E ratio 2022
14.3 x
Employees 171
Yield 2021 *
-
Yield 2022
2.76%
Free-Float 25.33%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.12%
1 week-5.41%
Current month+5.90%
1 month+5.90%
3 months-1.92%
6 months-5.21%
Current year+6.67%
More quotes
1 week
13.27
Extreme 13.27
14.35
1 month
12.07
Extreme 12.07
14.35
Current year
12.02
Extreme 12.02
14.93
1 year
9.23
Extreme 9.23
21.76
3 years
9.23
Extreme 9.23
25.03
5 years
9.23
Extreme 9.23
25.03
10 years
9.23
Extreme 9.23
25.03
More quotes
Managers TitleAgeSince
Founder 49 10/06/10
Chief Executive Officer 54 10/06/10
Director of Finance/CFO 37 30/11/20
Members of the board TitleAgeSince
Chief Executive Officer 54 10/06/10
Founder 49 10/06/10
Director of Finance/CFO 37 30/11/20
More insiders
Date Price Change Volume
30/04/24 13.28 -1.12% 1,732,555
29/04/24 13.43 -4.00% 2,351,359
26/04/24 13.99 -1.20% 1,528,647
25/04/24 14.16 +0.93% 3,021,144
24/04/24 14.03 -0.07% 2,699,917

Delayed Quote Borsa Istanbul, April 30, 2024 at 04:08 pm

More quotes
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret AS is a Turkey-based company, which is s a biotechnology company operating in accordance with ISO 9001, ISO 13485 and 98/79/EC Total Quality Systems. The Company's main activities are to develop and produce Real-Time Polymerase Chain Reaction (Real-Time PCR) kits, and to create a complete solution with automatic nucleic acid isolation devices and Real-Time PCR Systems. The main goals of the entity are to reduce Turkey's foreign dependency in molecular diagnostics and biotechnology and to gain success in the global market by developing and producing molecular genetic products.
More about the company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
13.28 TRY
Average target price
15.4 TRY
Spread / Average Target
+15.96%
Consensus